Emerging drugs for cancer-related pain

Supportive Care in Cancer

Volumn 19, Issue 12, 2011, Pages 1887-1893

  Mercadante, Sebastiano ^a,b  

^a LA MADDALENA CANCER CENTER   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ANALGESIC AGENT; CANNABINOID; CANNABIS; CODEINE; DEXTROMETHORPHAN; DULOXETINE; FENTANYL; FENTANYL BUCCAL TABLET; FULRANUMAB; GABAPENTIN; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NALOXONE PLUS OXYCODONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN MVIIA; ORAL TRANSMUCOSAL FENTANYL; OSTEOPROGENIN; OXYCODONE; PARACETAMOL; PLACEBO; PREGABALIN; RALFINAMIDE; TAPENTADOL; TETRODOTOXIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; ANALGESIA; CANCER PAIN; CANCER RESEARCH; COGNITIVE DEFECT; CONSTIPATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG TOLERABILITY; HEALTH CARE NEED; HUMAN; LIFE EXPECTANCY; NEUROPATHIC PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADJUVANTS, PHARMACEUTIC; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; PAIN; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 83555176071     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1281-y     Document Type: Review

References (41)

1. CE Argoff 2010 Clinical implications of opioid pharmacogenetics Clin J Pain 26 S16 S20 20026961 10.1097/AJP.0b013e3181c49e11
2. R Bell C Eccleston E Kalso 2003 Ketamine as adjuvant to opioids for caner pain. A qualitative systematic review Pain Symptom Manag 26 867 875 10.1016/S0885-3924(03)00311-7 1:CAS:528:DC%2BD3sXot1WjtLs%3D (Pubitemid 37101234)
3. MI Bennett 2011 Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review Palliat Med 25 553 559 20671006 10.1177/0269216310378546
4. A Caraceni E Zecca C Bonezzi, et al. 2004 Gabapentin for neuropathic cancer pain: a randomized controlled trial from a gabapentin J Clin Oncol 22 2909 2917 15254060 10.1200/JCO.2004.08.141 1:CAS:528:DC%2BD2cXpsVWktb0%3D (Pubitemid 41079911)
5. N Cherny C Ripamonti J Pereira C Davis M Fallon H McQuay S Mercadante G Pasternak V Ventafridda 2001 Strategies to manage the adverse effects of oral morphine: an evidence-based report J Clin Oncol 19 2542 2554 11331334 1:CAS:528:DC%2BD3MXjvVelu78%3D (Pubitemid 32391226)
6. KE Clemens G Mikus 2010 Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain Expert Opin Pharmacother 11 297 310 20030568 10.1517/14656560903483222 1:CAS:528:DC%2BC3cXhsVGrsr8%3D
7. A Davies A Dickman C Reid A Stevens J Zeppetella 2009 The management of cancer related breakthrough pain: recommendations of a task group of the Association for Palliative Medicine of Great Britain and Ireland Eur J Pain 13 330 337
8. AN Davies J Vriens A Kennett M McTaggart 2008 An observational study of oncology patients' utilization of breakthrough pain medication J Pain Symptom Manage 35 406 411 18222631 10.1016/j.jpainsymman.2007.05.010
9. A Delaney SM Fleetwood-Walker LA Colvin M Fallon 2008 Translational medicine: cancer pain mechanisms and management Br J Anaesth 101 87 94 18492671 10.1093/bja/aen100 1:STN:280:DC%2BD1czosVGqsQ%3D%3D (Pubitemid 351881906)
10. D Dudgeon E Bruera B Gagnon S Watanabe S Allan D Wart S MacDonald C Savage D Tu J Pater 2007 A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients J Pain Symptom Manage 33 365 371 17397698 10.1016/j.jpainsymman.2006.09.017 1:CAS:528: DC%2BD2sXltFOju7Y%3D (Pubitemid 46505075)
11. B Galer D Lee T Ma B Nagle T Schlagheck 2005 Morphidex (morphine sulphate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance Pain 115 284 295 15911155 10.1016/j.pain.2005.03.004 1:CAS:528:DC%2BD2MXks1Gnsrw%3D (Pubitemid 40725285)
12. DB Gordon JL Dahl C Miaskowski, et al. 2005 American Pain Society recommendations for improving the quality of acute and cancer pain management. American Pain Society Quality of Care Task Force Arch Intern Med 165 1574 1580 16043674 10.1001/archinte.165.14.1574 (Pubitemid 41124150)
13. N Hagen P du Souich B Lapointe M Ong-Lam B Dubuc D Walde R Love NA Ho 2008 Tetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter study J Pain Symptom Manag 35 420 429 10.1016/j.jpainsymman.2007.05.011 1:CAS:528:DC%2BD1cXlsV2nu7s%3D (Pubitemid 351410457)
14. GW Hanks Expert Working group of the Research Network of the European Association for Palliative Care 2001 Morphine and alternative opioids in cancer pain: the EAPC recommendations Br J Cancer 84 587 593 11237376 10.1054/bjoc.2001.1680 1:CAS:528:DC%2BD3MXisVerur8%3D (Pubitemid 32238990)
15. FF Helfi A Rosenthal PA Walicke, et al. 2006 Novel class of pain drugs based on antagonism of NGF Trend Pharm Sci 27 1 7 10.1016/j.tips.2005.11.003 (Pubitemid 43063115)
16. S Kaasa K Moksnes T Nolte D Lefebvre-Kuntz L Popper HG Kress 2010 Pharmacokinetics of intransal fentanyl spray in patients with cancer and breakthrough pain J Opioid Manag 6 17 25 20297611 10.5055/jom.2010.0001
17. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
18. J Johnson M Burnell-Nugent D Lossignol ED Ganae-Motan R Potts MT Fallon 2010 Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain J Pain Symptom Manage 39 167 179 19896326 10.1016/j.jpainsymman.2009.06.008
19. B Laird L Colvin M Fallon 2008 Management of cancer pain: basic principles and neuropathic cancer pain Eur J Cancer 44 1078 1082 18439818 10.1016/j.ejca.2008.03.022 1:STN:280:DC%2BD1czivVCnsA%3D%3D
20. B Lennernas I Frank-Lissbrant H Lennernas KM Kalkner R Derrick J Howel 2010 Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study Palliat Med 24 286 293 20015921 10.1177/0269216309356138
21. J Mao 2009 Translational pain research: achievements and challenges J Pain 10 1001 1011 19628433 10.1016/j.jpain.2009.06.002
22. E Martin-Sanchez T Furukawa J Taylor JL Martin 2009 Systematic review and meta-analysis of cannabis treatment for chronic pain Pain Med 10 1353 1366 19732371 10.1111/j.1526-4637.2009.00703.x
23. BE McGeeney 2008 Adjuvant agents in cancer pain Clin J Pain 24 suppl S14 S20 18418224 10.1097/AJP.0b013e31816b5976 (Pubitemid 351556395)
24. W Meissner P Leyendecker S Mueller-Lissner, et al. 2009 A randomized controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation Eur J Pain 13 56 64 18762438 10.1016/j.ejpain.2008.06.012 1:CAS:528:DC%2BD1MXjvFOjuw%3D%3D
25. S Mercadante 1999 Treatment and outcome of cancer pain in advanced cancer patients followed at home Cancer 85 1849 1858 10223581 10.1002/(SICI)1097- 0142(19990415)85:8<1849::AID-CNCR27>3.0.CO;2-6 1:STN:280: DyaK1M3jvVSqsA%3D%3D (Pubitemid 29169688)
26. S Mercadante 2007 Why are our patients still suffering? Clin Pract Nature Oncol 4 138 139 10.1038/ncponc0745 (Pubitemid 46358847)
27. S Mercadante E Bruera 2006 Opioid switching: a systematic and critical review Cancer Treat Rev 32 304 315 16624490 10.1016/j.ctrv.2006.03.001 1:CAS:528:DC%2BD28Xltlemu78%3D (Pubitemid 44502005)
28. S Mercadante L Radbruch A Caraceni N Cherny S Kaasa F Nauck C Ripamonti F De Conno Steering Committee of the European Association for Palliative Care (EAPC) Research Network 2002 Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Cancer 94 832 839 11857319 10.1002/cncr.10249 (Pubitemid 34132314)
29. S Mercadante L Radbruch A Davies P Poulain T Sittle P Perkins T Colberg MA Camba 2009 A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial Curr Med Res Opin 11 2805 2815
30. RK Portenoy J Thomas BM Moehl 2008 Subcutaneous methylnaltrexone for the treqtment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study J Pain Symptom Manage 35 458 468 18440447 10.1016/j.jpainsymman.2007.12.005 1:CAS:528:DC%2BD1cXntV2nt70%3D (Pubitemid 351601995)
31. RK Portenoy 1989 Cancer pain. Epidemiology and syndromes Cancer 63 2298 2307 2655867 10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3. 0.CO;2-A 1:STN:280:DyaL1M3kvVyhtg%3D%3D (Pubitemid 19141077)
32. RK Portenoy D Taylor J Messina L Tremmel 2006 A randomized, pladebo-controlled study of fentanyl buccal tablets for breakthrough pain in opioid-treated patients with cancer Clin J Pain 22 805 811 17057563 10.1097/01.ajp.0000210932.27945.4a (Pubitemid 44627444)
33. R Rauck M Tark E Reyes T Hayes A Bartkowiak S Nalamachu R Derrick J Howell 2009 Efficacy and long-term tolerbility of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain Curr Med Res Opin 25 2877 2885 19814586 10.1185/03007990903368310 1:CAS:528: DC%2BD1MXhsVCrsLrJ
34. JR Ross K Goller J Hardy, et al. 2005 Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study J Palliat Med 8 1118 2116 16351524 10.1089/jpm.2005.8.1118 1:STN:280: DC%2BD2MnmsFagtg%3D%3D (Pubitemid 43010543)
35. PS Staats T Yearwood SG Charapata RW Presley MS Wallace M Byas-Smith R Fisher DA Bryce EA Mangieri RR Luther M Mayo D McGuire D Ellis 2008 Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial Pain Med 9 271 281 18366507 10.1111/j.1526-4637. 2008.00445.x (Pubitemid 351736840)
36. J Thomas S Karver GA Cooney, et al. 2008 A randomized placebo-controlled trial of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness N Engl J Med 358 2332 2334 18509120 10.1056/NEJMoa0707377 1:CAS:528:DC%2BD1cXmsVKgsrg%3D (Pubitemid 351749157)
37. V Ventafridda M Tamburini A Caraceni F De Conno F Naldi 1987 A validation study of the WHO method for cancer pain relief Cancer 59 850 856 3802043 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1 1:STN:280:DyaL2s7gt1Ghsw%3D%3D (Pubitemid 17018769)
38. D Vissers W Stam T Nolte M Lenre J Jansen 2010 Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer Curr Med Res Opin 26 1037 1045 20199140 10.1185/03007991003694340 1:CAS:528: DC%2BC3cXkslOju74%3D
39. W Wade WJ Spruill 2009 Tapentadol hydrochloride: a centrally acting oral analgesic Clin Ther 31 2804 2818 20110020 10.1016/j.clinthera.2009.12.003 1:CAS:528:DC%2BC3cXhvVygurc%3D
40. + channel blocker, on firing properties of nociceptive dorsal root ganglion neurons of adult rats Exp Neurol 208 63 72 17707373 10.1016/j.expneurol.2007.07.010 1:CAS:528:DC%2BD2sXht1anurjI (Pubitemid 47600148)
41. DFJ Zech S Grond J Lynch D Hertel KA Lehmann 1995 Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study Pain 63 65 76 8577492 10.1016/0304-3959(95)00017-M 1:STN:280: DyaK287isVShtA%3D%3D